JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma: Trends in Immunology
Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma - Wikipedia
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
CHN1 is prognostic marker for diffuse large B-cell lymphoma | PGPM
Non-Hodgkin lymphoma - Clinical
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma
Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma
PDF) Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology
C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies | PLOS ONE
Diffuse Large B-Cell Lymphoma | NEJM
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
Frontiers | Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma - ScienceDirect
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/5-Figure2-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/6-Figure3-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/3-Figure1-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
CHN1 is prognostic marker for diffuse large B-cell lymphoma | PGPM
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
